GloNeuro

Autism

Autism is a lifelong difference in how the brain develops that affects how a person communicates and relates to others, and how they experience the world, including sensations such as sound, light and touch1,2. Autistic people vary widely in their strengths and support needs, and understanding, adjustments and appropriate support can make a substantial difference to wellbeing and quality of life1.

About 1 in 127 people (2021 estimate)People with autism worldwide1
About 1 in 100Median prevalence in studies since 20125
About 80%Estimated heritability6
None found in large studiesLink with childhood vaccines1,9

This information is for education. It is not medical advice and does not replace assessment by a qualified health professional. Anyone concerned about symptoms should consult a doctor; in an emergency, local emergency services should be contacted.

What it is

Autism, also called autism spectrum disorder (ASD), is a difference in brain development that affects social communication and interaction, and is associated with focused interests, repetitive behaviours and differences in sensory experience2,3. It is described as a spectrum because autistic people have a wide range of characteristics, strengths, needs and challenges12.

Autism is present from early development and is lifelong, but it is often not recognised or diagnosed until later childhood or adulthood1,2. Some autistic people live independently, while others have high support needs throughout life1. In prevalence studies, about a third of autistic people also have an intellectual disability, meaning significant difficulties with learning and reasoning5.

The language used about autism is debated. Many autistic adults prefer identity-first terms such as ‘autistic person’, whereas many professionals use person-first terms such as ‘person with autism’; no single term is universally preferred11.

The neurodiversity perspective, advanced largely by the autistic community, regards autism as one form of natural variation among human minds and challenges an exclusive focus on deficits10. Clinical services, meanwhile, aim to identify needs and offer support, and the perspectives of autistic people are increasingly considered in both research and practice3.

Signs and symptoms

Autistic characteristics differ greatly between individuals and can change over the lifespan; not every autistic person shows all of them1,12. Many autistic people also have particular strengths, such as learning things in great detail and remembering information for long periods12.

  • Differences in social communication, such as little or inconsistent eye contact, or difficulty with the back-and-forth of conversation12
  • Finding it hard to understand another person’s point of view or to adjust behaviour to different social situations12
  • Repetitive movements or speech, including repeating words or phrases (echolalia)12
  • Intense, long-lasting interests in particular topics, such as numbers, details or facts12
  • Distress at small changes in routine and difficulty moving from one activity to another1,12
  • Being more or less sensitive than other people to light, sound, touch, smell, taste or temperature2,12
  • Co-occurring conditions are common, including epilepsy, anxiety, depression, attention deficit hyperactivity disorder (ADHD) and sleep problems1,2,12

Causes and risk factors

There is no single known cause of autism. Current evidence points to a strong genetic contribution that interacts with environmental factors, mainly acting during early brain development, although how these factors combine is not well understood1,12.

Large studies have found no link between autism and vaccines, including the measles, mumps and rubella (MMR) vaccine and vaccine components such as thiomersal1,9. The study that originally suggested a link was shown to be fraudulent and was withdrawn by the journal that published it1.

Autism is diagnosed about four times more often in males than in females5. The following factors are associated with a higher likelihood of autism, but most people exposed to them are not autistic12.

  • Having a brother or sister who is autistic12
  • Older parental age1,12
  • Certain genetic conditions, such as fragile X syndrome and Down syndrome12
  • Premature birth, very low birth weight or severe birth complications1,12
  • Diabetes in the mother during pregnancy, and prenatal exposure to some medicines, such as valproate, or to air pollutants1

Genetics

Autism often runs in families. A study of more than two million children in five countries estimated its heritability, the share of differences between people in a population that is explained by genetic differences, at about 80%6. A high heritability does not mean that autism is caused by a single gene, or that the environment plays no part.

Much of the genetic influence comes from many common variants, each with a very small effect. A genome-wide association study (GWAS), which scans the genomes of thousands of people for shared variants, identified the first five regions robustly linked to autism7.

Rare variants also contribute. A large exome sequencing study, which reads the protein-coding parts of genes, implicated 102 genes, most of which are active early in brain development8. Many autism-linked variants are not specific to autism and are also found in people with other developmental conditions3,8.

What happens in the brain

Autism is not associated with obvious damage to the brain. Instead, post-mortem, brain imaging and electrophysiological studies, which record the brain’s electrical activity, have found subtle differences in brain structure and function at a group level3.

Genes linked to autism are often active while the cerebral cortex, the brain’s outer layer, is forming, and many influence how nerve cells develop or communicate with one another7,8. In developing human cortex, these genes are especially active in both excitatory nerve cells, which make other cells more likely to fire, and inhibitory nerve cells, which dampen activity8.

This has supported the idea that autism may involve a shift in the balance between excitation and inhibition in brain circuits8,16. This remains a hypothesis: some studies point to changes in excitation and others to changes in inhibition, the brain may partly compensate for such changes, and the underlying biology probably differs between individuals16,17.

Genetics and neuroscience have revealed patterns of risk, but these findings have not yet led to much practical benefit for autistic people4.

How it is diagnosed

There is no blood test or brain scan for autism. Diagnosis is based on a careful assessment of development and behaviour by experienced professionals, often working as a team12,15.

Autism can often be reliably diagnosed by around the age of two, although many people are identified later in childhood or as adults1,12.

  • Developmental monitoring at routine child health checks: in India, the Rashtriya Bal Swasthya Karyakram screens children from birth to 18 years for developmental delays and disabilities, including autism18, and in the United States autism-specific screening is recommended at 18 and 24 months12
  • Referral to a specialist autism team when parents, carers or professionals raise concerns15
  • A detailed developmental history from parents or carers, and observation of the person’s communication, play and social interaction12,15
  • Assessment of thinking skills, speech and language, and everyday living skills12
  • Medical and neurological examination, and assessment for co-occurring conditions such as ADHD, anxiety, depression or epilepsy12,14
  • For adults, NICE in the United Kingdom advises against routinely using biological tests, genetic tests or brain imaging to diagnose autism14

How scientists study it

Large genetic studies (GWAS and exome sequencing)

International consortia compare the DNA of tens of thousands of autistic and non-autistic people to find common and rare variants linked to autism7,8.

Population registers and family studies

Nationwide health registers that follow whole birth cohorts allow researchers to estimate heritability and to examine prenatal and family factors6.

Brain imaging and electrophysiology

Magnetic resonance imaging (MRI), functional MRI and electroencephalography (EEG) measure brain structure and activity; differences found are subtle and apply to groups rather than individuals3.

Gene expression in developing brain tissue

Maps of which cells in the developing human cortex switch on autism-linked genes help show when and where these genes act8.

Prevalence studies

Systematic reviews of studies from many countries track how often autism is identified and how this varies with awareness, services and population factors5.

Clinical trials of support approaches

Randomised trials test early psychosocial interventions, measuring outcomes such as joint attention, language and social engagement3.

Participatory research

Increasingly, autistic people are involved in setting research priorities and designing studies, reflecting the neurodiversity perspective3,10.

Current treatments

No cure; support-focused care

Autism is not an illness and there is no cure2. Support aims to meet each person’s own needs and goals, together with community and societal action for greater accessibility and inclusion1.

Early social-communication support

Play-based approaches delivered with parents, carers and teachers can increase joint attention (sharing focus on something with another person), engagement and two-way communication3,13.

Speech, occupational and educational support

Speech and language therapy, occupational therapy and educational support can help with communication, daily living skills and learning, building on the person’s strengths12.

Psychological therapies

Cognitive behavioural therapy (CBT), a talking therapy that works on thoughts and behaviours, can be adjusted to the needs of autistic children and young people with anxiety13.

Medicines for specific difficulties

No medicine treats the core features of autism, and NICE in the United Kingdom advises against using antipsychotics, antidepressants or anticonvulsants for this purpose13. Medicines may, however, be used for specific problems such as anxiety, depression, attention difficulties, irritability or sleep problems12,13.

Approaches to avoid

Indian clinical practice guidelines advise against therapies with poor evidence, such as stem cell therapy, chelation (drugs that remove metals from the body), secretin and gluten-free, casein-free diets19; NICE in the United Kingdom likewise advises against secretin, chelation and exclusion diets13,14.

Support for adults and families

Information, practical support and help with education, housing and employment should be matched to individual and changing needs1,12.

Research frontiers

Genetic diversity within autism

Larger genetic studies are beginning to show differences in genetic architecture between autistic subgroups, which may help explain why autism varies so much7,8.

Excitation-inhibition balance

Researchers are testing whether altered balance between excitatory and inhibitory brain signalling underlies some autistic characteristics8.

Lifespan and adult outcomes

Further research is needed on the long-term needs of autistic adults and on which supports improve independence and quality of life over time3,4.

Neurodiversity-informed science

Researchers are rethinking how autism research is framed, with less emphasis on deficits and more on context, strengths and autistic perspectives10.

Access to diagnosis worldwide

The prevalence of autism in many low- and middle-income countries is unknown, and improving recognition and services there is a priority1,5.

Living with the condition and seeking help

When autism is suspected in a child or an adult, an assessment can be discussed with a family doctor or other health professional, or with staff at the school or nursery12. The earlier autism is identified, the sooner support and services can begin12.

After diagnosis, autistic people and their carers should be offered information, services and practical support suited to their individual and changing needs1. Support groups and advocacy organisations, including those led by autistic people, can offer information and community12.

Autistic people are more likely than others to experience anxiety or depression2. If someone is in immediate danger, has seriously harmed themselves or is thinking about suicide, local emergency services or a crisis line should be contacted straight away, or the person should go to the nearest emergency department. In India, emergency help is available on 11220, and Tele-MANAS, the national tele-mental health service, offers free support at all hours on 1441621.

References

  1. World Health Organization. Autism (fact sheet). 17 September 2025. Link
  2. NHS (United Kingdom). What is autism? Page last reviewed 6 May 2026. Link
  3. Lord C, Brugha TS, Charman T, et al. Autism spectrum disorder. Nat Rev Dis Primers. 2020;6:5. doi:10.1038/s41572-019-0138-4 · PubMed
  4. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392:508-520. doi:10.1016/S0140-6736(18)31129-2 · PubMed
  5. Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: a systematic review update. Autism Res. 2022;15:778-790. doi:10.1002/aur.2696 · PubMed
  6. Bai D, Yip BHK, Windham GC, et al. Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiatry. 2019;76:1035-1043. doi:10.1001/jamapsychiatry.2019.1411 · PubMed
  7. Grove J, Ripke S, Als TD, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51:431-444. doi:10.1038/s41588-019-0344-8 · PubMed
  8. Satterstrom FK, Kosmicki JA, Wang J, et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell. 2020;180:568-584.e23. doi:10.1016/j.cell.2019.12.036 · PubMed
  9. Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32:3623-3629. doi:10.1016/j.vaccine.2014.04.085 · PubMed
  10. Pellicano E, den Houting J. Annual Research Review: Shifting from 'normal science' to neurodiversity in autism science. J Child Psychol Psychiatry. 2022;63:381-396. doi:10.1111/jcpp.13534 · PubMed
  11. Kenny L, Hattersley C, Molins B, Buckley C, Povey C, Pellicano E. Which terms should be used to describe autism? Perspectives from the UK autism community. Autism. 2016;20:442-462. doi:10.1177/1362361315588200 · PubMed
  12. National Institute of Mental Health, United States. Autism spectrum disorder (NIH publication). Revised 2025. Link
  13. National Institute for Health and Care Excellence (NICE), United Kingdom. Autism spectrum disorder in under 19s: support and management (CG170). Recommendations. 2013, updated 2021. Link
  14. National Institute for Health and Care Excellence (NICE), United Kingdom. Autism spectrum disorder in adults: diagnosis and management (CG142). Recommendations. 2012, updated 2021. Link
  15. National Institute for Health and Care Excellence (NICE), United Kingdom. Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128). Recommendations. 2011, updated 2017. Link
  16. Sohal VS, Rubenstein JLR. Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry. 2019;24:1248-1257. doi:10.1038/s41380-019-0426-0 · PubMed
  17. Nelson SB, Valakh V. Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron. 2015;87:684-698. doi:10.1016/j.neuron.2015.07.033 · PubMed
  18. National Health Mission, Ministry of Health and Family Welfare, Government of India. Rashtriya Bal Swasthya Karyakram (RBSK): child health screening and early intervention services. 2013. Link
  19. Subramanyam AA, Mukherjee A, Dave M, Chavda K. Clinical practice guidelines for autism spectrum disorders. Indian J Psychiatry. 2019;61(Suppl 2):254-269. doi:10.4103/psychiatry.IndianJPsychiatry_542_18 · PubMed
  20. Press Information Bureau, Government of India (Ministry of Women and Child Development). Panic button becomes available to women with launch of ERSS and pan-India emergency number 112. 19 February 2019. Link
  21. Press Information Bureau, Government of India (Ministry of Health and Family Welfare). Update on National Tele Mental Health Programme (NTMHP). 4 April 2025. Link

Prepared 15 October 2026.

Last updated